Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Annals of the Rheumatic Diseases

Ab0777 Identification of a Microrna Signature Predictive of Clinical Response to Tofacitinib in Patients With Rheumatoid Arthritis

View Full Paper
Ask AI
Bookmark
Share

Authors

ECEleonora CellettiMPMassimo PentaESEmanuela Sabatini

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Celletti et al. (2024) studied this question.

synapsesocial.com/papers/68e671afb6db6435875fbadbhttps://doi.org/10.1136/annrheumdis-2024-eular.3970
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1POS0107 IDENTIFICATION OF POTENTIAL GENES AND TREATMENT RESPONSE TO TOFACITINIB THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS2024
  2. 2Plasma miR-134-5p: A Candidate Biomarker For Predicting Non-Response To Anti-TNF Therapy In Rheumatoid Arthritis2026
  3. 3AB0653 IMPACT OF TSDMARD, TOFACITINIB, ON ENDOTHELIAL FUNCTION IN RA AND ITS ASSOCIATION WITH CELLULAR RATIOS2024
  4. 4P0655Mucosal cytokine pattern could predict therapeutic response to tofacitinib treatment in Ulcerative Colitis: Results from a Prospective Study2026
  5. 5Circulating immune cell biomarkers in Psoriatic Arthritis: associations with clinical manifestations and treatment response in the TOFA-PREDICT trial2026